Seelos Therapeutics, Inc.
SEELDelisted Apr 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001017491
Seelos Therapeutics, Inc. was delisted on Apr 4, 2025; its insiders filed their last Form 4 on Mar 1, 2024; 23 institutions reported holding it in 13F filings for Q2 2024, worth $129.4K in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Seelos Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −3 vs. Q4 2023
- Shares held
- 2.63M
- +842.5K (+47.2%) vs. Q4 2023
- Total value
- $1.55M
- −$927.8K (−37.4%) vs. Q4 2023
- New holders
- 6
- 12 more added
- Sold out
- 9
- 6 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SEEL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 3 | $4.77K |
| Q3 2024 | 15 | $145.2K |
| Q2 2024 | 23 | $129.4K |
| Q1 2024 | 36 | $1.55M |
| Q4 2023 | 39 | $2.48M |
| Q3 2023 | 82 | $7.01M |
| Q2 2023 | 83 | $27.1M |
| Q1 2023 | 80 | $15.1M |
| Q4 2022 | 80 | $15.6M |
| Q3 2022 | 85 | $28.0M |
| Q2 2022 | 86 | $21.3M |
| Q1 2022 | 92 | $33.0M |
| Q4 2021 | 97 | $65.9M |
| Q3 2021 | 110 | $98.2M |
| Q2 2021 | 105 | $107.8M |
| Q1 2021 | 73 | $124.8M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Seelos Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TSFG, LLC | 3 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 3 | $2 | 0.00% | +3 | New |
| The PNC Financial Services Group, Inc. | 12 | $8 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 33 | $9 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 28 | $17 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 33 | $19 | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 50 | $30 | 0.00% | 00.0% | Unchanged |
| Hollencrest Capital Management | 86 | $51 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 199 | $118 | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 372 | $219 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 440 | $260 | 0.00% | +69+18.6% | Added |
| Crewe Advisors LLC | 925 | $547 | 0.00% | 00.0% | Unchanged |
| Vermillion & White Wealth Management Group, LLC | 996 | $588 | 0.00% | +996 | New |
| Group One Trading, L.P. | 1,824 | $1.08K | 0.00% | −7,247−79.9% | Reduced |
| Bank of America Corp | 3,757 | $2.22K | 0.00% | −10.0% | Reduced |
| JPMorgan Chase & Co | 4,032 | $2.38K | 0.00% | +2,017+100.1% | Added |
| Carmichael Hill & Associates, Inc. | 8,000 | $4.73K | 0.00% | +3,000+60.0% | Added |
| Advisor Group Holdings, Inc. | 8,233 | $4.76K | 0.00% | −513−5.9% | Reduced |
| Wealth Enhancement Advisory Services, LLC | 10,018 | $5.92K | 0.00% | +10,018 | New |
| UBS Group AG | 10,166 | $6.01K | 0.00% | +9,759+2,397.8% | Added |
| Tower Research Capital LLC (TRC) | 10,517 | $6.22K | 0.00% | +5,237+99.2% | Added |
| CRA Financial Services, LLC | 11,889 | $7.03K | 0.00% | +11,889 | New |
| State Street Corp | 12,948 | $7.65K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 13,085 | $7.73K | 0.00% | −12,161−48.2% | Reduced |
| XTX Topco Ltd | 16,071 | $9.50K | 0.00% | +16,071 | New |
| Jane Street Group, LLC | 23,009 | $13.6K | 0.00% | +23,009 | New |
| Strategic Family Wealth Counselors, L.L.C. | 30,010 | $17.7K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 55,961 | $33.1K | 0.00% | −30.0% | Reduced |
| Geode Capital Management, LLC | 102,408 | $60.5K | 0.00% | +73,065+249.0% | Added |
| Morgan Stanley | 126,064 | $74.5K | 0.00% | +55,901+79.7% | Added |
| Modera Wealth Management, LLC | 157,617 | $93.2K | 0.00% | +87,889+126.0% | Added |
| Vanguard Group Inc | 280,866 | $166.0K | 0.00% | −3,012−1.1% | Reduced |
| Balyasny Asset Management LLC | 379,239 | $224.1K | 0.00% | +114,485+43.2% | Added |
| Gendell Jeffrey L | 428,966 | $253.5K | 0.01% | +317,351+284.3% | Added |
| AdvisorShares Investments LLC | 462,694 | $273.5K | 0.05% | +281,435+155.3% | Added |
| Wealth Effects LLC | 466,660 | $275.8K | 0.10% | +238,067+104.1% | Added |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −303,714−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −40,536−100.0% | Sold out |
| Lynwood Capital Management Inc. | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| LM Advisors LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −66−100.0% | Sold out |